Interstitial Cystitis
Atlas of Hunner's lesions and glomerulations and their correlations with bladder computed tomography findings in patients with interstitial cystitis.
- Details
This study presents characteristic cystoscopic findings for Hunner's and non-Hunner's interstitial cystitis/bladder pain syndrome (HIC and NHIC) and their association with bladder wall morphology assessed by computed tomography (CT) and urodynamic parameters.
Are We Missing the Bladder? Reflections on Endometriosis and IC/BPS.
- Details
Endometriosis and interstitial cystitis/bladder pain syndrome (IC/BPS) frequently coexist in women with chronic pelvic pain, yet overlapping symptoms and non-standardized diagnostic pathways often delay recognition of dual pathology.
Single-cell transcriptomics reveals bladder microenvironment dynamics in Hunner type interstitial cystitis.
- Details
Hunner type interstitial cystitis is a chronic inflammatory bladder disorder characterized by pain and severe lower urinary tract symptoms. Using single-cell RNA sequencing of Hunner lesions, non-Hunner lesions, and control bladder tissues, we characterized cellular states and intercellular communication within the bladder microenvironment.
TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: GUIDELINES FROM THE COMMITTEE OF FEMALE UROLOGY (CUROPF) OF THE FRENCH ASSOCIATION OF UROLOGY (AFU).
- Details
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a complex chronic condition requiring a multimodal and individualized management approach. This article presents current treatment recommendations for IC/BPS, covering the full therapeutic spectrum from lifestyle and dietary measures to last-resort surgical options.
Exploration and experimental validation of oxidative stress-related diagnostic genes in interstitial cystitis based on transcriptomics.
- Details
Interstitial cystitis (IC) is a chronic pain syndrome with an elusive diagnosis and poorly understood pathogenesis, in which oxidative stress (OS) is increasingly implicated. This study aimed to identify and validate OS-related diagnostic biomarkers for IC using an integrative computational and experimental approach.
DIAGNOSIS OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: GUIDELINES FROM THE COMMITTEE OF FEMALE UROLOGY (CUROPF) OF THE FRENCH ASSOCIATION OF UROLOGY (AFU).
- Details
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic condition whose diagnosis relies primarily on a structured process of exclusion. Defined as chronic pelvic pain, pressure, or discomfort perceived in relation to the bladder, accompanied by at least one urinary symptom, IC/BPS encompasses significant clinical and pathophysiological heterogeneity.
Development and multi-observer validation of a histopathological scoring system for interstitial cystitis/bladder pain syndrome diagnosis.
- Details
To develop and validate a pragmatic histopathological scoring system for interstitial cystitis/bladder pain syndrome (IC/BPS) that distinguishes Hunner-type interstitial cystitis (HIC) from bladder pain syndrome (BPS) and inflammatory non-HIC chronic cystitis mimicking Hunner lesions ("other cystitis").
Pain-centered symptom-language co-occurrence networks differ between interstitial cystitis/bladder pain syndrome and fibromyalgia in Reddit patient discourse.
- Details
Interstitial cystitis/bladder pain syndrome (IC/BPS) and fibromyalgia (FM) are chronic pain conditions frequently discussed within shared conceptual frameworks such as central sensitization. Despite this conceptual overlap, IC/BPS is clinically characterized by pelvic and urinary symptoms, whereas FM is associated with widespread pain, fatigue, sleep disturbance, and other systemic manifestations.
Intravesical HA/EGF Salvage Therapy for Hyaluronic Acid-Refractory Interstitial Cystitis/Bladder Pain Syndrome: A Small Retrospective Pilot Case Series.
- Details
Some patients with interstitial cystitis/bladder pain syndrome (IC/BPS) remain symptomatic despite prolonged intravesical hyaluronic acid (HA). We report a small retrospective pilot case series evaluating HA plus epidermal growth factor (HA/EGF) as salvage therapy in selected HA-refractory patients.
Interstitial Cystitis: Past, Present and Future-A Patient Perspective.
- Details
In recent decades, Interstitial Cystitis (IC) has experienced turbulent times with numerous changes in nomenclature, definitions and classification, often based on theories, ideologies and politics rather than on real patients and their real symptoms, and has been increasingly dominated by pain and psychology theories rather than down-to-earth urology.